Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-20T03:56:45.671Z Has data issue: false hasContentIssue false

Chapter 6 - Animal models of dementia

Published online by Cambridge University Press:  01 December 2016

By
Erik D. Roberson  and
Aimee W. Kao
Edited by
Bruce L. Miller  and
Bradley F. Boeve
Bruce L. Miller
Affiliation:
University of California, San Francisco
Bradley F. Boeve
Affiliation:
Mayo Clinic, Minnesota
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Behavioral Neurology of Dementia , pp. 77 - 93
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Karran, E., and Hardy, J. (2014). A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol 76, 185–205.CrossRefGoogle ScholarPubMed
Lu, H., Zou, Q., Gu, H., Raichle, M.E., Stein, E.A., and Yang, Y. (2012). Rat brains also have a default mode network. Proc Natl Acad Sci USA 109, 3979–3984.CrossRefGoogle ScholarPubMed
Roberson, E.D. (2012). Mouse models of frontotemporal dementia. Ann Neurol 72, 837–849.CrossRefGoogle ScholarPubMed
Tecott, L.H. (2003). The genes and brains of mice and men. Am J Psychiatry 160, 646–656.Google Scholar
Crawley, J.N. (2000). What’s Wrong with My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice. (New York, NY: Wiley-Liss).CrossRefGoogle ScholarPubMed
Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527.CrossRefGoogle ScholarPubMed
McGowan, E., Eriksen, J., and Hutton, M. (2006). A decade of modeling Alzheimer’s disease in transgenic mice. Trends Genet 22, 281–289.CrossRefGoogle Scholar
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E.M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000). High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20, 4050–4058.CrossRefGoogle ScholarPubMed
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F.S., and Cole, G. (1996). Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102.CrossRefGoogle ScholarPubMed
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P.A., et al. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94, 13287–13292.CrossRefGoogle ScholarPubMed
Chishti, M.A., Yang, D.S., Janus, C., Phinney, A.L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001). Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562–21570.CrossRefGoogle ScholarPubMed
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., and Saido, T.C. (2014). Single App knock-in mouse models of Alzheimer’s disease. Nat Neurosci 17, 661–663.CrossRefGoogle ScholarPubMed
Kobayashi, D.T., and Chen, K.S. (2005). Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer’s disease. Genes Brain and Behav 4, 173–196.CrossRefGoogle ScholarPubMed
Roberson, E.D., and Mucke, L. (2006). 100 years and counting: Prospects for defeating Alzheimer’s disease. Science 314, 781–784.CrossRefGoogle Scholar
Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.-Q., and Mucke, L. (2007). Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer’s disease mouse model. Science 316, 750–754.CrossRefGoogle ScholarPubMed
Irizarry, M.C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B.T. (1997). APPSw transgenic mice develop age-related Ab deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56, 965–973.CrossRefGoogle Scholar
Irizarry, M.C., Soriano, F., McNamara, M., Page, K.J., Schenk, D., Games, D., and Hyman, B.T. (1997). Ab deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17, 7053–7059.CrossRefGoogle Scholar
Takeuchi, A., Irizarry, M.C., Duff, K., Saido, T.C., Hsiao Ashe, K., Hasegawa, M., Mann, D.M., Hyman, B.T., and Iwatsubo, T. (2000). Age-related amyloid b deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 157, 331–339.CrossRefGoogle ScholarPubMed
Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R.E., Wyss-Coray, T., Mucke, L., and Mahley, R.W. (1999). Expression of human apolipoprotein E3 or E4 in the brains of Apoe–/– mice: Isoform-specific effects on neurodegeneration. J Neurosci 19, 4867–4880.CrossRefGoogle Scholar
Buttini, M., Yu, G.-Q., Shockley, K., Huang, Y., Jones, B., Masliah, E., Mallory, M., Yeo, T., Longo, F.M., and Mucke, L. (2002). Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation. J Neurosci 22, 10539–10548.CrossRefGoogle Scholar
Chin, J., Palop, J.J., Yu, G.-Q., Kojima, N., Masliah, E., and Mucke, L. (2004). Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J Neurosci 24, 4692–4697.CrossRefGoogle ScholarPubMed
Lanz, T.A., Carter, D.B., and Merchant, K.M. (2003). Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13, 246–253.CrossRefGoogle ScholarPubMed
Moolman, D.L., Vitolo, O.V., Vonsattel, J.P., and Shelanski, M.L. (2004). Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33, 377–387.CrossRefGoogle ScholarPubMed
Spires, T.L., Meyer-Luehmann, M., Stern, E.A., McLean, P.J., Skoch, J., Nguyen, P.T., Bacskai, B.J., and Hyman, B.T. (2005). Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25, 7278–7287.CrossRefGoogle ScholarPubMed
Wu, C.C., Chawla, F., Games, D., Rydel, R.E., Freedman, S., Schenk, D., Young, W.G., Morrison, J.H., and Bloom, F.E. (2004). Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses. Proc Natl Acad Sci USA 101, 7141–7146.CrossRefGoogle ScholarPubMed
Palop, J.J., Chin, J., and Mucke, L. (2006). A network dysfunction perspective on neurodegenerative diseases. Nature 443, 768–773.CrossRefGoogle ScholarPubMed
Selkoe, D.J. (2002). Alzheimer’s disease is a synaptic failure. Science 298, 789–791.CrossRefGoogle ScholarPubMed
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999). Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177.CrossRefGoogle Scholar
Nicoll, J.A., Barton, E., Boche, D., Neal, J.W., Ferrer, I., Thompson, P., Vlachouli, C., Wilkinson, D., Bayer, A., Games, D., et al. (2006). Ab species removal after Ab42 immunization. J Neuropathol Exp Neurol 65, 1040–1048.CrossRefGoogle ScholarPubMed
Holcomb, L., Gordon, M.N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97–100.CrossRefGoogle ScholarPubMed
Nicoll, J.A., Wilkinson, D., Holmes, C., Steart, P., Markham, H., and Weller, R.O. (2003). Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9, 448–452.CrossRefGoogle ScholarPubMed
Lesné, S., MT, K., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., and Ashe, K.H. (2006). A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352–357.CrossRefGoogle ScholarPubMed
Palop, J.J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E., and Mucke, L. (2003). Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer’s disease-related cognitive deficits. Proc Natl Acad Sci USA 100, 9572–9577.CrossRefGoogle ScholarPubMed
Westerman, M.A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L.H., Carlson, G.A., Younkin, S.G., and Ashe, K.H. (2002). The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci 22, 1858–1867.CrossRefGoogle Scholar
Cleary, J.P., Walsh, D.M., Hofmeister, J.J., Shankar, G.M., Kuskowski, M.A., Selkoe, D.J., and Ashe, K.H. (2005). Natural oligomers of the amyloid-b protein specifically disrupt cognitive function. Nat Neurosci 8, 79–84.CrossRefGoogle Scholar
Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., and Selkoe, D.J. (2002). Naturally secreted oligomers of amyloid b protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539.CrossRefGoogle ScholarPubMed
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.M., Perez-Tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996). Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713.CrossRefGoogle ScholarPubMed
Janus, C., D’Amelio, S., Amitay, O., Chishti, M.A., Strome, R., Fraser, P., Carlson, G.A., Roder, J.C., St George-Hyslop, P., and Westaway, D. (2000). Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging 21, 541–549.CrossRefGoogle ScholarPubMed
Borchelt, D.R., Ratovitski, T., Van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Copeland, N.G., Price, D.L., and Sisodia, S.S. (1997). Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939–945.CrossRefGoogle ScholarPubMed
Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006). Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 10129–10140.CrossRefGoogle Scholar
Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996). Familial Alzheimer’s disease-linked presenilin 1 variants elevate Ab1-42/1–40 ratio in vitro and in vivo. Neuron 17, 1005–1013.CrossRefGoogle Scholar
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., et al. (1996). Secreted amyloid b-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2, 864–870.CrossRefGoogle ScholarPubMed
Shen, J., and Kelleher, R.J. 3rd (2007). The presenilin hypothesis of Alzheimer’s disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 104, 403–409.CrossRefGoogle ScholarPubMed
Kasri, N.N., Kocks, S.L., Verbert, L., Hébert, S.S., Callewaert, G., Parys, J.B., Missiaen, L., and De Smedt, H. (2006). Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium 40, 41–51.CrossRefGoogle ScholarPubMed
LaFerla, F.M. (2002). Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3, 862–872.CrossRefGoogle ScholarPubMed
Leissring, M.A., Akbari, Y., Fanger, C.M., Cahalan, M.D., Mattson, M.P., and LaFerla, F.M. (2000). Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 149, 793–798.CrossRefGoogle ScholarPubMed
Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S.-F., Hao, Y.-H., Serneels, L., De Strooper, B., Yu, G., and Bezprozvanny, I. (2006). Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked mutations. Cell 126, 981–993.CrossRefGoogle ScholarPubMed
Baki, L., Shioi, J., Wen, P., Shao, Z., Schwarzman, A., Gama-Sosa, M., Neve, R., and Robakis, N.K. (2004). PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations. EMBO J 23, 2586–2596.CrossRefGoogle ScholarPubMed
Saura, C.A., Choi, S.Y., Beglopoulos, V., Malkani, S., Zhang, D., Shankaranarayana Rao, B.S., Chattarji, S., Kelleher, R.J. 3rd, Kandel, E.R., Duff, K., et al. (2004). Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23–36.CrossRefGoogle ScholarPubMed
Bertram, L., McQueen, M.B., Mullin, K., Blacker, D., and Tanzi, R.E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39, 17–23.CrossRefGoogle ScholarPubMed
Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N., and van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. J Am Med Assoc 278, 1349–1356.CrossRefGoogle Scholar
Raber, J., Huang, Y., and Ashford, J.W. (2004). ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25, 641–650.CrossRefGoogle Scholar
Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., et al. (1993). Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43, 1467–1472.CrossRefGoogle ScholarPubMed
Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R.W., and Huang, Y. (2006). Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 26, 4985–4994.CrossRefGoogle ScholarPubMed
Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R.E., Mahley, R.W., and Mucke, L. (1998). Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females. Proc Natl Acad Sci USA 95, 10914–10919.Google Scholar
Raber, J., Wong, D., Yu, G.-Q., Buttini, M., Mahley, R.W., Pitas, R.E., and Mucke, L. (2000). Alzheimer’s disease: Apolipoprotein E and cognitive performance. Nature 404, 352–354.Google Scholar
Payami, H., Zareparsi, S., Montee, K.R., Sexton, G.J., Kaye, J.A., Bird, T.D., Yu, C.E., Wijsman, E.M., Heston, L.L., Litt, M., et al. (1996). Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 58, 803–811.CrossRefGoogle ScholarPubMed
Raber, J. (2004). Androgens, apoE, and Alzheimer’s disease. Aging Knowledge Environ Mar 17, 11:re2.CrossRefGoogle ScholarPubMed
Raber, J., LeFevour, A., Buttini, M., and Mucke, L. (2002). Androgens protect against Apolipoprotein E4-induced cognitive deficits. J Neurosci 22, 5204–5209.CrossRefGoogle ScholarPubMed
Trommer, B.L., Shah, C., Yun, S.H., Gamkrelidze, G., Pasternak, E.S., Ye, G.L., Sotak, M., Sullivan, P.M., Pasternak, J.F., and LaDu, M.J. (2004). ApoE isoform affects LTP in human targeted replacement mice. Neuroreport 15, 2655–2658.CrossRefGoogle Scholar
Huang, Y., Liu, X.Q., Wyss-Coray, T., Brecht, W.J., Sanan, D.A., and Mahley, R.W. (2001). Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98, 8838–8843.CrossRefGoogle ScholarPubMed
Harris, F., Brecht, W.J., Xu, Q., Tesseur, I., Kekonius, L., Wyss-Coray, T., Fish, J.D., Masliah, E., Hopkins, P.C., Scearce-Levie, K., et al. (2003). Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer’s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci USA 100, 10966–10971.CrossRefGoogle ScholarPubMed
Holtzman, D.M., Bales, K.R., Tenkova, T., Fagan, A.M., Parsadanian, M., Sartorius, L.J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000). Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 97, 2892–2897.CrossRefGoogle Scholar
Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D., et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487–1491.CrossRefGoogle Scholar
Chabrier, M.A., Blurton-Jones, M., Agazaryan, A.A., Nerhus, J.L., Martinez-Coria, H., and LaFerla, F.M. (2012). Soluble Aβ promotes wild-type tau pathology in vivo. J Neurosci 32, 17345–17350.CrossRefGoogle ScholarPubMed
Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y., and LaFerla, F.M. (2003). Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Ab and synaptic dysfunction. Neuron 39, 409–421.CrossRefGoogle Scholar
Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H., and LaFerla, F.M. (2004). Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321–332.CrossRefGoogle ScholarPubMed
Perl, D.P., Olanow, C.W., and Calne, D. (1998). Alzheimer’s disease and Parkinson’s disease: Distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 44, S19–31.CrossRefGoogle ScholarPubMed
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., and Mucke, L. (2001). β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer’s disease and Parkinson’s disease. Proc Natl Acad Sci USA 98, 12245–12250.CrossRefGoogle ScholarPubMed
Hall, A.M., and Roberson, E.D. (2012). Mouse models of Alzheimer’s disease. Brain Res Bull 88(1), 3–12.CrossRefGoogle ScholarPubMed
LaFerla, F.M., and Green, K.N. (2012). Animal models of Alzheimer disease. Cold Spring Harb Perspect Med, Nov 1, 2(11).CrossRefGoogle ScholarPubMed
Puzzo, D., Lee, L., Palmeri, A., Calabrese, G., and Arancio, O. (2014). Behavioral assays with mouse models of Alzheimer’s disease: practical considerations and guidelines. Biochem Pharmacol 88, 450–467.CrossRefGoogle ScholarPubMed
Webster, S.J., Bachstetter, A.D., Nelson, P.T., Schmitt, F.A., and Van Eldik, L.J. (2014). Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Frontiers in Genetics 5, 88.CrossRefGoogle ScholarPubMed
Clark, L.N., Poorkaj, P., Wszolek, Z., Geschwind, D.H., Nasreddine, Z.S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., et al. (1998). Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 95, 13103–13107.CrossRefGoogle ScholarPubMed
Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705.CrossRefGoogle ScholarPubMed
Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M., and Schellenberg, G.D. (1998). Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43, 815–825.CrossRefGoogle ScholarPubMed
Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., and Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95, 7737–7741.CrossRefGoogle Scholar
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Paul Murphy, M., Baker, M., Yu, X., et al. (2000). Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25, 402–405.CrossRefGoogle ScholarPubMed
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005). Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476–481.CrossRefGoogle ScholarPubMed
Sydow, A., Van der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., Drexler, D., Zhou, L., Rune, G., Mandelkow, E., et al. (2011). Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci 31, 2511–2525.CrossRefGoogle ScholarPubMed
Clavaguera, F., Bolmont, T., Crowther, R.A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A.K., Beibel, M., Staufenbiel, M., et al. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11, 909–913.CrossRefGoogle Scholar
Sanders, D.W., Kaufman, S.K., DeVos, S.L., Sharma, A.M., Mirbaha, H., Li, A., Barker, S.J., Foley, A.C., Thorpe, J.R., Serpell, L.C., et al. (2014). Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271–1288.CrossRefGoogle ScholarPubMed
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D.H., Kopeikina, K.J., Pitstick, R., Sahara, N., Ashe, K.H., Carlson, G.A., et al. (2012). Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 73, 685–697.CrossRefGoogle Scholar
Roberson, E.D. (2006). Frontotemporal dementia. Curr Neurol Neurosci Rep 6, 481–489.CrossRefGoogle ScholarPubMed
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, J.Q., and Lee, V.M. (2007). Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337–351.CrossRefGoogle Scholar
Forman, M.S., Lal, D., Zhang, B., Dabir, D.V., Swanson, E., Lee, V.M., and Trojanowski, J.Q. (2005). Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci 25, 3539–3550.CrossRefGoogle ScholarPubMed
Dabir, D.V., Robinson, M.B., Swanson, E., Zhang, B., Trojanowski, J.Q., Lee, V.M., and Forman, M.S. (2006). Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 26, 644–654.CrossRefGoogle ScholarPubMed
Baker, M., Mackenzie, I.R., Pickering-Brown, S.M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A.D., Rollinson, S., et al. (2006). Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916–919.CrossRefGoogle ScholarPubMed
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.J., et al. (2006). Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920–924.CrossRefGoogle ScholarPubMed
Ahmed, Z., Sheng, H., Xu, Y.F., Lin, W.L., Innes, A.E., Gass, J., Yu, X., Hou, H., Chiba, S., Yamanouchi, K., et al. (2010). Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am J Pathol 177, 311–324.CrossRefGoogle ScholarPubMed
Yin, F., Banerjee, R., Thomas, B., Zhou, P., Qian, L., Jia, T., Ma, X., Ma, Y., Iadecola, C., Beal, M.F., et al. (2010a). Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207, 117–128.Google ScholarPubMed
Yin, F., Dumont, M., Banerjee, R., Ma, Y., Li, H., Lin, M.T., Beal, M.F., Nathan, C., Thomas, B., and Ding, A. (2010b). Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. FASEB J 24, 4639–4647.CrossRefGoogle ScholarPubMed
Smith, K.R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S.E., Staropoli, J.F., et al. (2012). Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 90, 1102–1107.CrossRefGoogle ScholarPubMed
Filiano, A.J., Martens, L.H., Young, A.H., Warmus, B.A., Zhou, P., Diaz-Ramirez, G., Jiao, J., Zhang, Z., Huang, E.J., Gao, F.B., et al. (2013). Dissociation of frontotemporal dementia–related deficits and neuroinflammation in progranulin haploinsufficient mice. J Neurosci 33, 5352–5361.CrossRefGoogle ScholarPubMed
Kraemer, B.C., Schuck, T., Wheeler, J.M., Robinson, L.C., Trojanowski, J.Q., Lee, V.M., and Schellenberg, G.D. (2010). Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol 119, 409–419.CrossRefGoogle ScholarPubMed
Sephton, C.F., Good, S.K., Atkin, S., Dewey, C.M., Mayer, P. 3rd, Herz, J., and Yu, G. (2010). TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem 285, 6826–6834.CrossRefGoogle ScholarPubMed
Wu, L.S., Cheng, W.C., Hou, S.C., Yan, Y.T., Jiang, S.T., and Shen, C.K. (2010). TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 48, 56–62.CrossRefGoogle ScholarPubMed
Iguchi, Y., Katsuno, M., Niwa, J., Takagi, S., Ishigaki, S., Ikenaka, K., Kawai, K., Watanabe, H., Yamanaka, K., Takahashi, R., et al. (2013). Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 136, 1371–1382.CrossRefGoogle ScholarPubMed
Shan, X., Chiang, P.M., Price, D.L., and Wong, P.C. (2010). Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci USA 107, 16325–16330.CrossRefGoogle ScholarPubMed
Stallings, N.R., Puttaparthi, K., Luther, C.M., Burns, D.K., and Elliott, J.L. (2010). Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis 40, 404–414.CrossRefGoogle ScholarPubMed
Wegorzewska, I., Bell, S., Cairns, N.J., Miller, T.M., and Baloh, R.H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 106, 18809–18814.CrossRefGoogle ScholarPubMed
Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C., and Kumar-Singh, S. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 107, 3858–3863.CrossRefGoogle ScholarPubMed
Xu, Y.F., Gendron, T.F., Zhang, Y.J., Lin, W.L., D’Alton, S., Sheng, H., Casey, M.C., Tong, J., Knight, J., Yu, X., et al. (2010). Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30, 10851–10859.CrossRefGoogle ScholarPubMed
Badadani, M., Nalbandian, A., Watts, G.D., Vesa, J., Kitazawa, M., Su, H., Tanaja, J., Dec, E., Wallace, D.C., Mukherjee, J., et al. (2010). VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One 5, e13183.CrossRefGoogle ScholarPubMed
Custer, S.K., Neumann, M., Lu, H., Wright, A.C., and Taylor, J.P. (2010). Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet 19, 1741–1755.CrossRefGoogle ScholarPubMed
Ghazi-Noori, S., Froud, K.E., Mizielinska, S., Powell, C., Smidak, M., Fernandez de Marco, M., O’Malley, C., Farmer, M., Parkinson, N., Fisher, E.M., et al. (2012). Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain 135, 819–832.CrossRefGoogle ScholarPubMed
Tsao, W., Jeong, Y.H., Lin, S., Ling, J., Price, D.L., Chiang, P.M., and Wong, P.C. (2012). Rodent models of TDP-43: recent advances. Brain Res 1462, 26–39.CrossRefGoogle ScholarPubMed
Morgan, T.H. (1910). Sex limited inheritance in Drosophila. Science 32, 120–122.CrossRefGoogle ScholarPubMed
Brenner, S. (1973a). The genetics of behaviour. Br Med Bull 29, 269–271.CrossRefGoogle ScholarPubMed
Brenner, S. (1973b). The genetics of behaviour. Br Med Bull 29, 269–271.CrossRefGoogle ScholarPubMed
Grunwald, D.J., Kimmel, C.B., Westerfield, M., Walker, C., and Streisinger, G. (1988). A neural degeneration mutation that spares primary neurons in the zebrafish. Dev Biol 126, 115–128.CrossRefGoogle ScholarPubMed
Bargmann, C.I. (1998). Neurobiology of the Caenorhabditis elegans genome. Science 282, 2028–2033.CrossRefGoogle ScholarPubMed
Yoshihara, M., Ensminger, A.W., and Littleton, J.T. (2001a). Neurobiology and the Drosophila genome. Funct Integr Genomics 1, 235–240.CrossRefGoogle ScholarPubMed
Yoshihara, M., Ensminger, A.W., and Littleton, J.T. (2001b). Neurobiology and the Drosophila genome. Funct Integr Genomics 1, 235–240.CrossRefGoogle ScholarPubMed
Lima, S.Q. and Miesenbock, G. (2005). Remote control of behavior through genetically targeted photostimulation of neurons. Cell 121, 141–152.CrossRefGoogle ScholarPubMed
Feany, M.B., and Bender, W.W. (2000a). A Drosophila model of Parkinson’s disease. Nature 404, 394–398.CrossRefGoogle ScholarPubMed
Feany, M.B., and Bender, W.W. (2000b). A Drosophila model of Parkinson’s disease. Nature 404, 394–398.CrossRefGoogle Scholar
Araya, C.L., Kawli, T., Kundaje, A., Jiang, L., Wu, B., Vafeados, D., Terrell, R., Weissdepp, P., Gevirtzman, L., Mace, D., et al. (2014). Regulatory analysis of the C. elegans genome with spatiotemporal resolution. Nature 512, 400–405.CrossRefGoogle ScholarPubMed
Brown, J.B., Boley, N., Eisman, R., May, G.E., Stoiber, M.H., Duff, M.O., Booth, B.W., Wen, J., Park, S., Suzuki, A.M., et al. (2014). Diversity and dynamics of the Drosophila transcriptome. Nature 512, 393–399.CrossRefGoogle ScholarPubMed
Gerstein, M.B., Rozowsky, J., Yan, K.K., Wang, D., Cheng, C., Brown, J.B., Davis, C.A., Hillier, L., Sisu, C., Li, J.J., et al. (2014). Comparative analysis of the transcriptome across distant species. Nature 512, 445–448.CrossRefGoogle ScholarPubMed
Rubin, G.M., Yandell, M.D., Wortman, J.R., Gabor Miklos, G.L., Nelson, C.R., Hariharan, I.K., Fortini, M.E., Li, P.W., Apweiler, R., Fleischmann, W., et al. (2000). Comparative genomics of the eukaryotes. Science 287, 2204–2215.CrossRefGoogle ScholarPubMed
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811.CrossRefGoogle ScholarPubMed
Torroja, L., Packard, M., Gorczyca, M., White, K., and Budnik, V. (1999b). The Drosophila β-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci 19, 7793–7803.CrossRefGoogle ScholarPubMed
Torroja, L., Chu, H., Kotovsky, I., and White, K. (1999). Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol 9, 489–492.CrossRefGoogle ScholarPubMed
Leyssen, M., Ayaz, D., Hébert, S.S., Reeve, S., De Strooper, B., and Hassan, B.A. (2005). Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J 24, 2944–2955.CrossRefGoogle ScholarPubMed
Gunawardena, S. and Goldstein, L.S.B. (2001). Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389–401.CrossRefGoogle Scholar
Link, C.D., Taft, A., Kapulkin, V., Duke, K., Kim, S., Fei, Q., Wood, D.E., and Sahagan, B.G. (2003). Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer’s disease model. Neurobiol Aging 24, 397–413.CrossRefGoogle Scholar
Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993). A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464.CrossRefGoogle ScholarPubMed
Cohen, E., Bieschke, J., Perciavalle, R.M., Kelly, J.W., and Dillin, A. (2006). Opposing activities protect against age-onset proteotoxicity. Science 313, 1604–1610.CrossRefGoogle Scholar
Kraemer, B.C., Zhang, B., Leverenz, J.B., Thomas, J.H., Trojanowski, J.Q., and Schellenberg, G.D. (2003). Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci USA 100, 9980–9985.CrossRefGoogle ScholarPubMed
Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M., and Feany, M.B. (2001). Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711–714.CrossRefGoogle ScholarPubMed
Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S., and Geschwind, D.H. (2002). Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509–519.CrossRefGoogle ScholarPubMed
Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805–810.Google Scholar
Guthrie, C.R., Greenup, L., Leverenz, J.B., and Kraemer, B.C. (2011). MSUT2 is a determinant of susceptibility to tau neurotoxicity. Hum Mol Genet: epub.CrossRefGoogle ScholarPubMed
Guthrie, C.R., Schellenberg, G.D., and Kraemer, B.C. (2009). SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum Mol Genet 18, 1825–1838.CrossRefGoogle Scholar
Nishimura, I., Yang, Y., and Lu, B. (2004). PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116, 671–682.CrossRefGoogle ScholarPubMed
Karsten, S.L., Sang, T.K., Gehman, L.T., Chatterjee, S., Liu, J., Lawless, G.M., Sengupta, S., Berry, R.W., Pomakian, J., Oh, H.S., et al. (2006). A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron 51, 549–560.CrossRefGoogle ScholarPubMed
Frost, B., Hemberg, M., Lewis, J., and Feany, M.B. (2014). Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci 17, 357–366.CrossRefGoogle ScholarPubMed
Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J., Vande Velde, C., Bouchard, J.P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40, 572–574.CrossRefGoogle ScholarPubMed
Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133.CrossRefGoogle ScholarPubMed
Ihara, R., Matsukawa, K., Nagata, Y., Kunugi, H., Tsuji, S., Chihara, T., Kuranaga, E., Miura, M., Wakabayashi, T., Hashimoto, T., et al. (2013). RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum Mol Genet 22, 4474–4484.CrossRefGoogle ScholarPubMed
Kabashi, E., Lin, L., Tradewell, M.L., Dion, P.A., Bercier, V., Bourgouin, P., Rochefort, D., Bel Hadj, S., Durham, H.D., Vande Velde, C., et al. (2010). Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19, 671–683.CrossRefGoogle ScholarPubMed
Li, Y., Ray, P., Rao, E.J., Shi, C., Guo, W., Chen, X., Woodruff, E.A. 3rd, Fushimi, K., and Wu, J.Y. (2010). A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci USA 107, 3169–3174.CrossRefGoogle ScholarPubMed
Schmid, B., Hruscha, A., Hogl, S., Banzhaf-Strathmann, J., Strecker, K., van der Zee, J., Teucke, M., Eimer, S., Hegermann, J., Kittelmann, M., et al. (2013). Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci USA 110, 4986–4991.CrossRefGoogle ScholarPubMed
Vaccaro, A., Tauffenberger, A., Aggad, D., Rouleau, G., Drapeau, P., and Parker, J.A. (2012). Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PLoS One 7, e31321.Google Scholar
Zhang, T., Mullane, P.C., Periz, G., and Wang, J. (2011). TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling. Hum Mol Genet 15,20(10),1952–1965.CrossRefGoogle ScholarPubMed
Kao, A.W., Eisenhut, R.J., Herl Martens, L., Nakamura, A., Huang, A., Bagley, J.A., Zhou, P., de Luis, A., Neukomm, L.J., Cabello, J., et al. (2011). A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells. Proc Natl Acad Sci USA 108, 4441–4446.CrossRefGoogle ScholarPubMed
Judy, M.E., Nakamura, A., Huang, A., Grant, H., McCurdy, H., Weiberth, K.F., Gao, F., Coppola, G., Kenyon, C., and Kao, A.W. (2013). A shift to organismal stress resistance in programmed cell death mutants. PLoS Genet 9, e1003714.CrossRefGoogle ScholarPubMed
Chitramuthu, B.P., Baranowski, D.C., Kay, D.G., Bateman, A., and Bennett, H.P. (2010). Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Mol Neurodegener 5, 41.CrossRefGoogle ScholarPubMed
Laird, A.S., Van Hoecke, A., De Muynck, L., Timmers, M., Van den Bosch, L., Van Damme, P., and Robberecht, W. (2010). Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS One 5, e13368.CrossRefGoogle Scholar
De Muynck, L., Herdewyn, S., Beel, S., Scheveneels, W., Van Den Bosch, L., Robberecht, W., and Van Damme, P. (2013). The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding. Neurobiol Aging 34, 2541–2547.CrossRefGoogle ScholarPubMed
DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J., et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245–256.CrossRefGoogle ScholarPubMed
Xu, Z., Poidevin, M., Li, X., Li, Y., Shu, L., Nelson, D.L., Li, H., Hales, C.M., Gearing, M., Wingo, T.S., et al. (2013). Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci USA 110, 7778–7783.CrossRefGoogle Scholar
Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A., and Kabashi, E. (2013). Loss of function of C9ORF72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 74, 180–187.CrossRefGoogle ScholarPubMed
Therrien, M., Rouleau, G.A., Dion, P.A., and Parker, J.A. (2013). Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS One 8, e83450.CrossRefGoogle ScholarPubMed
Mizielinska, S., and Isaacs, A.M. (2014). C9ORF72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function? Curr Opin Neurol 27, 515–523.CrossRefGoogle ScholarPubMed
Mizielinska, S., Gronke, S., Niccoli, T., Ridler, C.E., Clayton, E.L., Devoy, A., Moens, T., Norona, F.E., Woollacott, I.O., Pietrzyk, J., et al. (2014). C9ORF72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345, 1192–1194.CrossRefGoogle ScholarPubMed
Liu, L., Drouet, V., Wu, J.W., Witter, M.P., Small, S.A., Clelland, C., and Duff, K. (2012). Trans-synaptic spread of tau pathology in vivo. PLoS One 7, e31302.Google Scholar
Cruts, M., and Rademakers, R. Alzheimer Disease & Frontotemporal Dementia Mutation Database: http://www.molgen.ua.ac.be/ADMutations/default.cfm?MT=3&ML=1&Page=Cite.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×